AstraZeneca US trials thrown into doubt after promising data

Sombre UK marks one year since first virus lockdown
23 March 2021
Precautions used to prevent COVID-19 decreased common respiratory illness rates, study finds
23 March 2021

AstraZeneca US trials thrown into doubt after promising data

A US health agency raised concerns Tuesday that AstraZeneca may have included out-of-date information during trials of its COVID-19 vaccine, a day after the company said its drug was highly effective in preventing the disease.

Comments are closed.